Spotlight on Sotorasib (AMG 510) for KRASG12C Positive Non-Small Cell Lung Cancer
Shannon S Zhang,1 Misako Nagasaka1– 3 1Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, USA; 3St. Marianna University School of Medicine, Kawasaki, JapanCorrespondence: Misako NagasakaDepartment of Medi...
Main Authors: | Zhang S, Nagasaka M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-10-01
|
Series: | Lung Cancer : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/spotlight-on-sotorasib-amg-510-for-krasg12c-positive-non-small-cell-lu-peer-reviewed-fulltext-article-LCTT |
Similar Items
-
Naproxen inhibits spontaneous lung adenocarcinoma formation in KrasG12V mice
by: Gaurav Kumar, et al.
Published: (2021-06-01) -
Severe Immune Checkpoint Inhibitor Hepatitis in KRAS G12C-Mutant NSCLC Potentially Triggered by Sotorasib: Case Report
by: Parvin Begum, MBChB.(Hons), et al.
Published: (2021-09-01) -
Early detection of pre-malignant lesions in a KRASG12D-driven mouse lung cancer model by monitoring circulating free DNA
by: Callum P. Rakhit, et al.
Published: (2019-02-01) -
Apoptosis-inducing activity of synthetic hydrocarbon-stapled peptides in H358 cancer cells expressing KRASG12C
by: Cuicui Li, et al.
Published: (2021-09-01) -
KRAS G12C Mutations in NSCLC: From Target to Resistance
by: Alfredo Addeo, et al.
Published: (2021-05-01)